Skip to main content
Clinical Trials/IRCT2014011213739N2
IRCT2014011213739N2CompletedPhase 1

A randomized controlled trial comparing the effects of ß-D-Mannuronic acid and immunosuppressive drugs on disease activity and inflammatory markers in patients with Rheumatoid Arthritis

Vice-Chancellor for Research, Tehran University of Medical Sciences0 sites35 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Completed
Sponsor
Enrollment
35

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
25 years to 60 years (—)
Sex
All

Inclusion Criteria

  • Inclusion Criteria: 25-60 years old patients diagnosed with RA according to American College of Rheumatology Diagnostic Criteria after the initial visit by a specialist in rheumatology and parameters ESR, RF, CRP and Anti-CCP elected. Also each patient must sign written informed consent.

Exclusion Criteria

  • History of fever and infectious diseases, positive pregnancy test or lactation, other collagen- vascular diseases, other auto-immune diseases, malignancies, patients have enrolled another Clinical Trial study within last 4 weeks, other concomitant diseases (Hepatic, renal, haematological, gastrointestinal, endocrine, cardiovascular, pulmonary, neurological or cerebral disease)

Investigators

Sponsor
Vice-Chancellor for Research, Tehran University of Medical Sciences

Similar Trials